Bloomberg Billionaires Index

View profiles for each of the world’s 500 richest people, see the biggest movers, and compare fortunes or track returns.

# 110 Zhong Huijuan $12.7B

Random fact: Hansoh's chemotherapy drug has about 40 percent of China market.

Overview

Zhong is the founder and chairman of Hansoh Pharmaceutical Group, China's largest maker of psychotropic drugs. The Liangyungang-based company produces about 50 medicines to treat conditions including diabetes, infection and diseases of the nervous system. It had revenue of 7.7 billion yuan ($1.1 billion) in 2018.

As of :
Last change -$622M ( -4.7%)
YTD change +$6.44B ( +102.8%)
Industry Health Care
Biggest asset 3692 HK Equity
Citizenship China
Age 58
Wealth Self-made
View net worth over:   Max 1 year 1 quarter 1 month 1 week

Relative Value

Zhong Huijuan's net worth of $12.7B can buy ...

0
troy ounces of gold
0
barrels of crude oil

... and is equivalent to ...

0%
of the GDP of the United States
0%
of the total wealth of the 500 richest people in the world
0%
of the top 100 U.S. college endowments
0%
of the top 200 U.S. executives’ total awarded compensation
0%
of U.S. existing home sales
0
times the median U.S. household income

Latest News

Net Worth Summary

Cash
Private asset
Public asset
Misc. liabilities
Confidence rating:

Zhong's fortune is derived from her 68% stake in Hansoh Pharmaceutical Group Company, a Chinese drug maker, according to the company's prospectus for a 2019 initial public offering.

Zhong holds her stake through The Sunrise Trust, which was registered in the British Virgin Islands by her daughter in 2016, according to the prospectus. Zhong is credited with all of the stake to reflect her status as founder and chairman of the business.

Zhong has collected about $750 million in dividends since Hansoh was set up in 1995, according to the prospectus.

Iris Luo, a spokesperson for the company, declined to comment on the billionaire's net worth.

Biography

Birthdate:
Family: Married, 1 child
Education: Nanjing University, Xuzhou Normal University

Born in 1961, Zhong obtained an undergraduate degree in chemistry from Jiangsu Normal University in Xuzhou at the age of 21. She became a chemistry teacher in a middle school in Lianyungang, China, after graduation. Zhong's husband Sun Piaoyang worked at a government-run pharmaceutical factory in Lianyungang at that time, which later became Jiangsu Hengrui Medicine.

Zhong quit her teaching job in 1995 and started her own medicine business Jiangsu Hansoh Pharmaceutical. She began with just 10 employees, according to an interview in the Chinese media. The company began growing quickly in 1997 and had reached 30 million yuan ($4 million) in sales in the same year.

The Liangyungang-based business reported revenue of 7.7 billion yuan in 2019, according to the company's 2019 IPO prospectus. It's main therapeutic areas are central nervous systems diseases, oncology, anti-infectives, diabetes, gastrointestinal and cardiovascular.

Milestones
  • 1995 Set up jiangsu Hansoh in China.
  • 2000 Launched the first factory for oral formulations in Lianyungang.
  • 2016 Hillhouse Capital became Hansoh's investor.
  • 2018 Submitted IPO application in Hong Kong.